Cargando…
Orchestrated activation of mGluR5 and CB(1) promotes neuroprotection
The metabotropic glutamate receptor 5 (mGluR5) and the cannabinoid receptor 1 (CB(1)) exhibit a functional interaction, as CB(1) regulates pre-synaptic glutamate release and mGluR5 activation increases endocannabinoid synthesis at the post-synaptic site. Since both mGluR5 and CB(1) promote neuroprot...
Autores principales: | Batista, Edleusa M. L., Doria, Juliana G., Ferreira-Vieira, Talita H., Alves-Silva, Juliana, Ferguson, Stephen S. G., Moreira, Fabricio A., Ribeiro, Fabiola M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992217/ https://www.ncbi.nlm.nih.gov/pubmed/27543109 http://dx.doi.org/10.1186/s13041-016-0259-6 |
Ejemplares similares
-
mGluR5, CB1 and neuroprotection
por: Carvalho, Toniana G., et al.
Publicado: (2016) -
mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington’s disease phenotype
por: de Souza, Jessica M., et al.
Publicado: (2022) -
mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington’s disease
por: de Souza, Jéssica M., et al.
Publicado: (2020) -
Group I mGluRs in Therapy and Diagnosis of Parkinson’s Disease: Focus on mGluR5 Subtype
por: Azam, Shofiul, et al.
Publicado: (2022) -
Metabotropic glutamate receptors (mGluRs) in epileptogenesis: an update on abnormal mGluRs signaling and its therapeutic implications
por: Huang, Leyi, et al.
Publicado: (2023)